Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists.

Publication

Citation
Kiyoi T, Adam JM, Clark JK, Davies K, Easson AM, Edwards D, Feilden H, Fields R, Francis S, Jeremiah F, McArthur D, Morrison AJ, Prosser A, Ratcliffe PD, Schulz J, Wishart G, Baker J, Campbell R, Cottney JE, Deehan M, Epemolu O, Evans L.: Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists. Bioorg Med Chem Lett, Volume 21 (6), 2011
Authors
Adam JM, Baker J, Campbell R, Clark JK, Cottney JE, Davies K, Deehan M, Easson AM, Edwards D, Epemolu O, Evans L., Feilden H, Fields R, Francis S, Jeremiah F, Kiyoi T, McArthur D, Morrison AJ, Prosser A, Ratcliffe PD, Schulz J, Wishart G
Journal
Bioorg Med Chem Lett
Year
2011
PubMed
21316962
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists. | MolMeDB